Transcriptional Regulation of Antibody Responses and Immunity
- Institution
- University of Arizona, AZ
- Principal investigator
- Deepta Bhattacharya
- Funding
- $525K
- Duration
- 2012–2028
Moonbase score
Still being scored
Abstract
ABSTRACT The duration of antibody-mediated immunity varies widely with the specific immunization or infection for reasons that remain difficult to understand or predict. The specific features of molecular circuitry in B cells and plasma cells that are responsible for these differences have still not been defined. In this application, which requests a second renewal of our R01 award, we seek to objectively define 1) molecular programs and cellular trajectories that lead to long-lived plasma cells in primary responses; 2) transcriptional and epigenetic features of memory B cells that precede durable recall responses. We will employ two BTB-POZ transcription factors that functionally oppose each other to gain molecular footholds on programs that control plasma cell lifespan. Modern single cell transcriptional and epigenetic programs will be employed alongside classic model antigens and adjuvants and new genetic tools to manipulate genes in vivo. Though the experimental plan is fundamental and basic in nature, the hope is that this work will lead to a set of rules that help predict and optimize the duration of humoral immunity.
LOADING MOONBASE SCORE
Questions for University of Arizona
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · University of ArizonaNot yet scored
Glucose and Amino Acid Catabolism in Plasma Cell Biology
Deepta Bhattacharya · $587K · 2017–2027
- NIH · University of Arizona73
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
Roberta Eileen Brinton · $6.6M · 2019–2026
- NIH · University of Arizona70
Tracking autobiographical thoughts: a smartphone-based approach to identifying cognitive correlates of Alzheimer's disease biomarkers and risk factors in clinically normal older adults
Jessica Renee Andrews-Hanna · $965K · 2022–2028